ArticleMedical oncology (Northwood, London, England)2008
Breast cancer with an unusual leukemia-like presentation: case report and literature review.
Article in Medical oncology (Northwood, London, England), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 12 citations in OpenAlex.
- Carcinocythemia detection in peripheral blood smears: a literature review.Advances in laboratory medicine · 2026Review
- Breast cancer manifested by hematologic disorders.Journal of thoracic disease · 2012Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Breast cancer is the most common cancer in women in the world and the second-most common cancer in women in Taiwan. However, breast cancer with plentiful leukemia blast-like cells circulating in the peripheral blood is very rare. A 48-year-old woman with breast cancer and leukemia-like manifestations was admitted in August, 2006. Special staining and immunophenotyping studies to determine the origin of her peripheral blast cells confirmed that they were from her breast carcinoma. Carcinocythemia (carcinoma cell leukemia) was diagnosed and then systemic chemotherapy and hormone therapy were given. Nevertheless, she expired 9 months after carcinocythemia presentation. The differential diagnosis of this condition, which is complicated by chemotherapy or radiotherapy for solid tumors, is very important. Patients with carcinocythemia have poor prognosis and survival.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.